Compare · ISRG vs RBOT
ISRG vs RBOT
Side-by-side comparison of Intuitive Surgical Inc. (ISRG) and Vicarious Surgical Inc. (RBOT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ISRG and RBOT operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ISRG is the larger of the two at $162.07B, about 227.0x RBOT ($714.1M).
- Over the past year, ISRG is down 11.5% and RBOT is down 77.0% - ISRG leads by 65.5 points.
- ISRG has been more active in the news (14 items in the past 4 weeks vs 4 for RBOT).
- ISRG has more recent analyst coverage (25 ratings vs 6 for RBOT).
- Company
- Intuitive Surgical Inc.
- Vicarious Surgical Inc.
- Price
- $457.98+0.93%
- $1.99-0.75%
- Market cap
- $162.07B
- $714.1M
- 1M return
- -0.64%
- +0.00%
- 1Y return
- -11.48%
- -77.03%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2000
- 2020
- News (4w)
- 14
- 4
- Recent ratings
- 25
- 6
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Vicarious Surgical Inc.
Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Latest ISRG
- Director Reed Monica P converted options into 531 shares, increasing direct ownership by 23% to 2,876 units (SEC Form 4)
- Director Nachtsheim Jami K converted options into 531 shares, increasing direct ownership by 8% to 6,902 units (SEC Form 4)
- Director Leonard Keith R converted options into 531 shares, increasing direct ownership by 144% to 901 units (SEC Form 4)
- Director Ladd Amy L converted options into 531 shares, increasing direct ownership by 442% to 651 units (SEC Form 4)
- Director Kolli Sreelakshmi converted options into 531 shares, increasing direct ownership by 54% to 1,510 units (SEC Form 4)
- Director Johnson Amal M converted options into 531 shares, increasing direct ownership by 4% to 13,545 units (SEC Form 4)
- Director Chew Lewis converted options into 531 shares, increasing direct ownership by 68% to 1,314 units (SEC Form 4)
- Director Beery Joseph C converted options into 531 shares, increasing direct ownership by 17% to 3,641 units (SEC Form 4)
- Director Barratt Craig H converted options into 750 shares (SEC Form 4)
- Director Ladd Amy L sold $291,886 worth of shares (619 units at $471.55) as part of a pre-agreed trading plan, decreasing direct ownership by 84% to 120 units (SEC Form 4)
Latest RBOT
- SEC Form 10-Q filed by Vicarious Surgical Inc.
- Vicarious Surgical Reports First Quarter 2026 Financial Results
- Vicarious Surgical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Amendment: SEC Form SCHEDULE 13D/A filed by Vicarious Surgical Inc.
- Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair
- Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing
- SEC Form DEF 14A filed by Vicarious Surgical Inc.
- SEC Form 25-NSE filed by Vicarious Surgical Inc.
- SEC Form PRE 14A filed by Vicarious Surgical Inc.
- Vicarious Surgical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits